5-oxo-ETE receptor antagonist compounds
    38.
    发明授权
    5-oxo-ETE receptor antagonist compounds 有权
    5-氧代-ETE受体拮抗剂化合物

    公开(公告)号:US08809382B2

    公开(公告)日:2014-08-19

    申请号:US13318697

    申请日:2010-05-04

    摘要: The present invention relates to novel pharmaceutically-useful compounds which are antagonists of the 5-oxo-ETE receptors, such as the OXE receptor. These compounds have use as therapeutic and/or prophylactic agents for diseases characterized by tissue eosinophilia, such as inflammatory conditions including respiratory diseases. The invention also relates to pharmaceutical compositions, to the use of such compounds and compositions as medicaments, and to therapeutic methods.

    摘要翻译: 本发明涉及作为5-氧代-ETE受体(如OXE受体)的拮抗剂的新颖的药学上有用的化合物。 这些化合物可用作用于组织嗜酸性粒细胞增多症,特别是包括呼吸系统疾病在内的炎性疾病的疾病的治疗和/或预防剂。 本发明还涉及药物组合物,使用这些化合物和组合物作为药物,以及治疗方法。